Abstract
Purpose
To evaluate the clinical outcomes of platelet-rich fibrin (PRF) application for hemostasis after dental extraction in patients receiving anticoagulant therapy with factor Xa inhibitors.
Methods
In total, 25 patients receiving anticoagulant therapy with rivaroxaban or apixaban who required routine dental extraction were evaluated. In all patients, PRF was used for hemostasis in addition to adapting sutures. Bleeding was subjectively assessed using a sterilize gauze pad at 24, 48, and 72 h after the procedure.
Results
All invited participants (n = 25) consented to participate. The PRF clots successfully arrested bleeding after extraction in all patients, with no complications at any time point after the procedure. Favorable soft tissue healing was observed during suture removal at 10 days after the procedure in all patients, with no signs of infection or late healing.
Conclusions
The results of this case series indicate that PRF is a promising natural hemostatic agent for the management of bleeding after dental extraction in patients receiving factor Xa inhibitor therapy. Further controlled clinical studies with larger patient samples are necessary to clarify the findings of this case series.
Similar content being viewed by others
References
Blinder D, Manor Y, Martinowitz U, Taicher S (2001) Dental extractions in patients maintained on oral anticoagulant therapy: comparison of INR value with occurrence of postoperative bleeding. Int J Oral Maxillofac Surg 30:518–521
Firriolo FJ, Hupp WS (2012) Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients. Oral Surg Oral Med Oral Pathol Oral Radiol 113:431–441
Malden N (2005) Dental procedures can and undertaken without alteration of oral anticoagulant regimen. Evid Based Dent 6:11
Costantinides F, Rizzo R, Pascazio L, Maglione M (2016) Managing patients taking oral anticoagulants (NOAs) in dentistry: a discussion paper on clinical implications. BMC Oral Health 16:5–9
O’Dell KM, Igawa D, Hsin J (2012) New oral anticoagulants for atrial fibrillation : a review of clinical trials. Clin Ther 3(4):894–901
O’Connell JE, Stassen LF (2014) New oral anticoagulants and their implications for dental patients. J Go Dent Assoc 60:137–143
Carter G, Goss A (2003) Tranexamic acid mouthwash : a prospective randomized study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions. Int J Oral Maxillofac Surg 32:504–507
Aframian DJ, Lalla RV, Peterson DE (2007) Management of dental patients taking common hemostasis-altering medications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103:S45.e1–S45.11
Bacci C, Maglione M, Favero L, Perini A, Di Lenarda R, Berengo M et al (2010) Management of dental extraction in patients undergoing anticoagulant treatment. Results from a large, multicentre, prospective, case- control study. Thromb Haemost 104:972–975
Perry DJ, Noakes TJ, Helliwell THE (2007) British Dental Society. Guidelines for the management of patients on oral anticoagulants requiring dental surgery. Br Dent J 203:389–393
Bajkin BV, Selakovié SD, Mirkovié SN, Šarčev IN, Tadič AJ, Milekič BR (2014) Comparison of efficacy of local hemostatic modalities in anticoagulated patients undergoing tooth extractions. Vojnosanit Pregl 71:1097–1101
de Almeida Barros Mourão CF, Calasans-Maia MD, de Mello Machado RC, de Brito Resende RF, Alves GG (2018) The use of platelet-rich fibrin as a hemostatic material in oral soft tissues. Oral Maxillofac Surg 22:329–333
Sammartino G, Dohan Ehrenfest DM, Carile F, Tia M, Bucci P (2011) Prevention of hemorrhagic complications after dental extractions into open heart surgery patients under anticoagulant therapy: the use of leukocyte- and platelet-rich fibrin. J Oral Implantol 37:681–690
Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, Kiene H, Helfand M, Altman DG, Sox H, Werthmann PG, Moher D, Rison RA, Shamseer L, Koch CA, Sun GH, Hanaway P, Sudak NL, Kaszkin-Bettag M, Carpenter JE, Gagnier JJ (2017) CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol 89:218–235
Miron R, Choukroun J, Ghanaati S (2018) Controversies related to scientific report describing g-forces from studies on platelet-rich fibrin: necessity for standardization of relative centrifugal force values. Int J Growth Factors Stem Cells Dent 1:80–89
Blinder D, Manor Y, Martinowitz U, Taicher S, Hashomer T (1999) Dental extractions in patients maintained on continued oral anticoagulant: comparison of local hemostatic modalities. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:137–140
Karsli ED, Erdogan O, Esen E, Acarturk E (2011) Comparison of the effects of warfarin and heparin on bleeding caused by dental extraction: a clinical study. J Oral Maxillofac Surg 69:2500–2507
Scully C, Wolff A (2002) Oral surgery in patients on anticoagulant therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:57–64
Queiroz SIML, Alves HS, de Assis GM, Conceicao TS, Germano AR, da Silva JS (2016) An evaluation of the efficacy of local hemostatic measures in dental patients taking oral anticoagulants: a critical review of the literature over the past two decades. Curr Clin Pharmacol 11:230–240
Moran IJ, Richardson L, Heliotis M, Bewick A (2017) A bleeding socket after tooth extraction. BMJ. 3(357):j1217
Hoaglin DR, Lines GK (2013) Prevention of localized osteitis in mandibular third- molar sites using platelet-rich fibrin. Int J Dent 2013:875380
Eshghpour M, Danaeifar N, Kermani H, Nejat AH (2018) Does intra-alveolar application of chlorhexidine gel in combination with platelet-rich fibrin have an advantage over application of platelet-rich fibrin in decreasing alveolar osteitis after mandibular third molar surgery? A double-blinded randomized clinical trial. J Oral Maxillofac Surg 76:939.e1–939.e7
Daugela P, Grimuta V, Sakavicius D, Jonaitis J, Juodzbalys G (2018) Influence of leukocyte- and platelet-rich fibrin (L-PRF) on the outcomes of impacted mandibular third molar removal surgery: a split-mouth randomized clinical trial. Quintessence Int 49:377–388
Jeyaraj PE, Chakranarayan A (2018) Soft tissue healing and bony regeneration of impacted mandibular third molar extraction sockets, following postoperative incorporation of platelet-rich fibrin. Ann Maxillofac Surg 8:10–18
Del Fabbro M, Bucchi C, Lolato A, Corbella S, Testori T, Taschieri S (2017) Healing of postextraction sockets preserved with autologous platelet concentrates. A systematic review and meta-analysis. J Oral Maxillofac Surg 75:1601–1615
Al-Hamed FS, Tawfik MAM, Abdelfadil E, Al-Saleh MAQ (2017) Efficacy of platelet-rich fibrin after mandibular third molar extraction: a systematic review and meta-analysis. Oral Maxillofac Surg 75:1124–1135
He Y, Chen J, Huang Y, Pan Q, Nie M (2017) Local application of platelet rich fibrin during lower third molar extraction improves treatment outcomes. J Oral Maxillofac Surg 75:2497–2506
Castro AB, Meschi N, Temmerman A, Pinto N, Lambrechts P, Teughels W, Quirynen M (2017) Regenerative potential of leucocyte- and platelet-rich fibrin. Part B: sinus floor elevation, alveolar ridge preservation, and implant therapy. A systematic review. J Clin Periodontol 44:225–234
Canellas JVS, Ritto FG, Medeiros PJD (2017) Evaluation of postoperative complications after mandibular third molar surgery with the use of platelet-rich fibrin: a systematic review and meta-analysis. Int J Oral Maxillofac Surg 46:1138–1146
Velier M, Magalon J, Daumas A, Cassar M, Francois P, Ghazouane A, Philandrianos C, Bertrand B, Frere C, Bernot D, Villani P, George FD, Sabatier F (2018) Production of platelet-rich plasma gel from elderly patients under antithrombotic drugs: perspectives in chronic wounds care. Platelets 29:496–503
Weisel JW, Rustem-Litvinov I (2017) Fibrin formation, structure and properties subcell. Biochem 82:405–456
Caliskan M, Tükel HC, Benlidayi ME, Deniz A (2017) Is it necessary to alter anticoagulation therapy for tooth extraction in patients taking direct oral anticoagulants? Med Oral Patol Oral Cir Bucal 22:e767–e773
Author information
Authors and Affiliations
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
de Almeida Barros Mourão, C., Miron, R.J., de Mello Machado, R.C. et al. Usefulness of platelet-rich fibrin as a hemostatic agent after dental extractions in patients receiving anticoagulant therapy with factor Xa inhibitors: a case series. Oral Maxillofac Surg 23, 381–386 (2019). https://doi.org/10.1007/s10006-019-00769-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10006-019-00769-y